Log In
BCIQ
Print this Print this
 

Testim, testosterone

  Manage Alerts
Collapse Summary General Information
Company Endo International plc
DescriptionTopical 1% testosterone gel
Molecular Target Androgen receptor
Mechanism of ActionAndrogen receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypogonadism
Indication DetailsTreat hypogonadism; Treat hypogonadism in HIV-positive men who did not have adequate releif with AndroGel treatment; Treat hypogonadism in men
Regulatory Designation
PartnerBayer AG;
Endo International plc;
Ipsen Group;
Xstelos Holdings Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/11/2014

Undisclosed

Undisclosed

Undisclosed

05/28/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today